• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肿瘤外血管侵犯是非小细胞肺癌的一个重要预后指标和远处转移的预测因素。

Extratumoral vascular invasion is a significant prognostic indicator and a predicting factor of distant metastasis in non-small cell lung cancer.

机构信息

Division of Thoracic Surgery, Research Center for Innovative Oncology, National Cancer Center Hospital East, Kashiwa, Chiba, Japan.

出版信息

J Thorac Oncol. 2010 Jul;5(7):970-5. doi: 10.1097/JTO.0b013e3181dd1803.

DOI:10.1097/JTO.0b013e3181dd1803
PMID:20512073
Abstract

INTRODUCTION

Vascular invasion is thought to be a fundamental step in hematogenous metastasis. The aim of this study was to assess whether the qualitative evaluation of vascular invasion according to its location (intratumoral or extratumoral) could provide an appropriate means of predicting the prognostic outcome and potential patterns of recurrence in non-small cell lung cancer.

METHODS

We reviewed the cases of 1000 consecutive patients in whom complete resection of non-small cell lung cancer had been performed. Sections stained by the Victoria blue van Gieson method were examined for the presence of vascular invasion and the evaluation of its location (v0: absence, n = 540; v1: intratumoral, n = 428; v2: extratumoral, n = 32). Survival was estimated using the Kaplan-Meier method. To determine independent prognostic factors, univariate and multivariate analyses were conducted.

RESULTS

The study cohort included 605 men and 395 women, with a mean age of 66 years (range, 20-90 years). The 5-year overall survival rate of the vascular invasion-negative group and the vascular invasion-positive group was 82.5% and 55.1%, respectively (p < 0.001), and the 5-year overall survival rates of the v1 group and v2 groups were 55.9% and 44.0%, respectively (p = 0.010). Multivariate analysis showed that location of the vascular invasion (v0-1 versus v2) (p = 0.049), age (p = 0.030), tumor size (p = 0.004), lymph node metastasis (p < 0.001), and pleural invasion (p < 0.001) were significant prognostic factors. The proportion of patients who developed distant metastasis was significantly higher in the v2 group than in the v1 group (p = 0.026).

CONCLUSION

Evaluation of vascular invasion location was a statistically significant predictor of prognosis and potential recurrence patterns.

摘要

介绍

血管侵犯被认为是血行转移的一个基本步骤。本研究旨在评估根据其位置(肿瘤内或肿瘤外)对血管侵犯进行定性评估是否可以为非小细胞肺癌的预后结果和潜在复发模式提供适当的预测手段。

方法

我们回顾了 1000 例连续接受非小细胞肺癌完全切除术患者的病例。使用维多利亚蓝范古森法染色的切片检查血管侵犯的存在及其位置的评估(v0:无,n=540;v1:肿瘤内,n=428;v2:肿瘤外,n=32)。使用 Kaplan-Meier 方法估计生存情况。为了确定独立的预后因素,进行了单因素和多因素分析。

结果

研究队列包括 605 名男性和 395 名女性,平均年龄为 66 岁(范围,20-90 岁)。血管侵犯阴性组和阳性组的 5 年总生存率分别为 82.5%和 55.1%(p<0.001),v1 组和 v2 组的 5 年总生存率分别为 55.9%和 44.0%(p=0.010)。多因素分析显示,血管侵犯的位置(v0-1 与 v2)(p=0.049)、年龄(p=0.030)、肿瘤大小(p=0.004)、淋巴结转移(p<0.001)和胸膜侵犯(p<0.001)是显著的预后因素。v2 组患者远处转移的比例明显高于 v1 组(p=0.026)。

结论

评估血管侵犯的位置是预测预后和潜在复发模式的统计学上显著的预测指标。

相似文献

1
Extratumoral vascular invasion is a significant prognostic indicator and a predicting factor of distant metastasis in non-small cell lung cancer.肿瘤外血管侵犯是非小细胞肺癌的一个重要预后指标和远处转移的预测因素。
J Thorac Oncol. 2010 Jul;5(7):970-5. doi: 10.1097/JTO.0b013e3181dd1803.
2
Prognostic impact of vascular and lymphovascular invasion in early lung cancer.血管及淋巴管侵犯对早期肺癌的预后影响
Asian Cardiovasc Thorac Ann. 2014 Jan;22(1):55-64. doi: 10.1177/0218492313478431. Epub 2013 Sep 4.
3
Prognostic impact of intratumoural microvascular invasion and microlymphatic permeation on node-negative non-small-cell lung cancer: which indicator is the stronger prognostic factor?肿瘤内微血管侵犯和微淋巴管渗透对淋巴结阴性非小细胞肺癌的预后影响:哪个指标是更强的预后因素?
Eur J Cardiothorac Surg. 2013 Apr;43(4):772-7. doi: 10.1093/ejcts/ezs396. Epub 2012 Aug 3.
4
Most peripheral, node-negative, non-small-cell lung cancers have low proliferative rates and no intratumoral and peritumoral blood and lymphatic vessel invasion. Rationale for treatment with wedge resection alone.大多数外周型、淋巴结阴性的非小细胞肺癌增殖率低,且无肿瘤内及肿瘤周围的血液和淋巴管侵犯。这是仅采用楔形切除术治疗的理论依据。
J Thorac Cardiovasc Surg. 1992 Oct;104(4):892-9.
5
Lymphatic invasion predicts survival in patients with early node-negative non-small cell lung cancer.淋巴血管侵犯可预测早期淋巴结阴性非小细胞肺癌患者的生存。
J Thorac Cardiovasc Surg. 2013 Oct;146(4):781-7. doi: 10.1016/j.jtcvs.2013.04.037. Epub 2013 Jun 15.
6
Proposal on incorporating blood vessel invasion into the T classification parts as a practical staging system for stage I non-small cell lung cancer.关于将血管侵犯纳入 T 分期部分作为 I 期非小细胞肺癌实用分期系统的建议。
Lung Cancer. 2013 Aug;81(2):187-93. doi: 10.1016/j.lungcan.2013.04.016. Epub 2013 May 8.
7
Prognostic significance of intratumoral blood vessel invasion in pathologic stage IA non-small cell lung cancer.肿瘤内血管侵犯对病理分期 IA 期非小细胞肺癌的预后意义。
Ann Thorac Surg. 2010 Mar;89(3):864-9. doi: 10.1016/j.athoracsur.2009.09.047.
8
Pathological vascular invasion and tumor differentiation predict cancer recurrence in stage IA non-small-cell lung cancer after complete surgical resection.完全手术切除后,病理性血管侵犯和肿瘤分化可预测 IA 期非小细胞肺癌的癌症复发。
J Thorac Oncol. 2012 Aug;7(8):1263-70. doi: 10.1097/JTO.0b013e31825cca6e.
9
Prognostic value and therapeutic consequences of vascular invasion in non-small cell lung carcinoma.非小细胞肺癌中血管侵犯的预后价值及治疗后果
Lung Cancer. 2009 Apr;64(1):71-8. doi: 10.1016/j.lungcan.2008.07.011. Epub 2008 Sep 14.
10
Prognostic impact of lymphovascular invasion compared with that of visceral pleural invasion in patients with pN0 non-small-cell lung cancer and a tumor diameter of 2 cm or smaller.在肿瘤直径为 2cm 或以下且无区域淋巴结转移(pN0)的非小细胞肺癌患者中,脉管侵犯与脏层胸膜侵犯的预后影响比较。
J Surg Res. 2013 Nov;185(1):250-4. doi: 10.1016/j.jss.2013.05.104. Epub 2013 Jun 22.

引用本文的文献

1
Peritumoral Radiomic Features on CT for Differential Diagnosis in Small-Cell Lung Cancer: Potential for Surgical Decision-Making.CT上小细胞肺癌鉴别诊断的瘤周放射组学特征:手术决策的潜力
Cancer Control. 2025 Jan-Dec;32:10732748251351754. doi: 10.1177/10732748251351754. Epub 2025 Jun 16.
2
Integration of intratumoral and peritumoral CT radiomic features with machine learning algorithms for predicting induction therapy response in locally advanced non-small cell lung cancer.整合瘤内和瘤周CT影像组学特征与机器学习算法以预测局部晚期非小细胞肺癌诱导治疗反应
BMC Cancer. 2025 Mar 13;25(1):461. doi: 10.1186/s12885-025-13804-x.
3
A nomogram based on CT intratumoral and peritumoral radiomics features preoperatively predicts poorly differentiated invasive pulmonary adenocarcinoma manifesting as subsolid or solid lesions: a double-center study.
一项基于术前CT肿瘤内及肿瘤周围影像组学特征的列线图可预测表现为亚实性或实性病变的低分化浸润性肺腺癌:一项双中心研究。
Front Oncol. 2024 Jan 19;14:1289555. doi: 10.3389/fonc.2024.1289555. eCollection 2024.
4
Extracellular vesicle-associated microRNA signatures related to lymphovascular invasion in early-stage lung adenocarcinoma.早期肺腺癌中与淋巴管血管侵犯相关的细胞外囊泡相关 microRNA 特征。
Sci Rep. 2023 Mar 24;13(1):4823. doi: 10.1038/s41598-023-32041-5.
5
Integrative nomogram of intratumoral, peritumoral, and lymph node radiomic features for prediction of lymph node metastasis in cT1N0M0 lung adenocarcinomas.基于肿瘤内、肿瘤旁和淋巴结放射组学特征的综合列线图预测 cT1N0M0 肺腺癌淋巴结转移
Sci Rep. 2021 May 24;11(1):10829. doi: 10.1038/s41598-021-90367-4.
6
Optimising use of 4D-CT phase information for radiomics analysis in lung cancer patients treated with stereotactic body radiotherapy.优化 4D-CT 相位信息在立体定向体部放疗治疗肺癌患者的放射组学分析中的应用。
Phys Med Biol. 2021 May 24;66(11):115012. doi: 10.1088/1361-6560/abfa34.
7
Combination of Peri- and Intratumoral Radiomic Features on Baseline CT Scans Predicts Response to Chemotherapy in Lung Adenocarcinoma.基线CT扫描上肿瘤周围和瘤内放射组学特征的组合可预测肺腺癌对化疗的反应。
Radiol Artif Intell. 2019 Mar 20;1(2):e180012. doi: 10.1148/ryai.2019180012.
8
Peritumoral radiomics features predict distant metastasis in locally advanced NSCLC.瘤周放射组学特征可预测局部晚期 NSCLC 的远处转移。
PLoS One. 2018 Nov 2;13(11):e0206108. doi: 10.1371/journal.pone.0206108. eCollection 2018.
9
Lymph microvascularization as a prognostic indicator in neuroblastoma.淋巴微血管生成作为神经母细胞瘤的预后指标
Oncotarget. 2018 May 25;9(40):26157-26170. doi: 10.18632/oncotarget.25457.
10
Prognostic Factors for Post Recurrence Survival in Resected Pathological Stage I Non-small Cell Lung Cancer.切除的病理I期非小细胞肺癌复发后生存的预后因素
Yonago Acta Med. 2018 Feb 5;60(4):213-219. doi: 10.24563/yam.2017.12.001. eCollection 2017 Dec.